US tech firm Disconnect has filed a complaint to EU antitrust regulators against Google’s ban on its privacy app, accusing the Silicon Valley giant of abusing its dominant market position.
Disconnect, set up four years ago by former Google engineers, says its app protects users of the Android operating system from invisible tracking and malware distributed through advertisements.
It said Google had abused its position by blocking the app from the Google Play store last year, and had gained an unfair advantage over competitors by integrating its own privacy and security services into its own products.
“They said we interfered with the ability of third parties to serve ads. Google was not willing to engage in a dialogue,” Disconnect Chief Executive Casey Oppenheim told Reuters on Tuesday.
Google said Disconnect’s complaint was groundless.
“Our Google Play policies have long prohibited apps that interfere with other apps – such as altering their functionality, or removing their way of making money. We apply this policy uniformly and Android developers strongly support it,” spokesman Al Verney said.
The European Commission, which opened a probe into Google’s agreements with smartphone and tablet makers using its Android operating system in April, confirmed it had received the complaint on Tuesday and said it would assess it.
Full content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas